{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:55:13Z","timestamp":1793256913892,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-02262990"],"award-info":[{"award-number":["RS-2025-02262990"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013129","name":"Korea Ministry of Small and Medium Enterprises and Startups","doi-asserted-by":"publisher","award":["RS-2023-00239221"],"award-info":[{"award-number":["RS-2023-00239221"]}],"id":[{"id":"10.13039\/501100013129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["NRF-2023R1AC3003438"],"award-info":[{"award-number":["NRF-2023R1AC3003438"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["RS-2025-02572971"],"award-info":[{"award-number":["RS-2025-02572971"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xcrm.2026.102939","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:36:40Z","timestamp":1785163000000},"page":"102939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Gfral silencing via antisense oligonucleotides ameliorates cancer-associated cachexia and extends survival in tumor-bearing mice"],"prefix":"10.1016","volume":"7","author":[{"given":"Hyun Jung","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyeon","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Woo","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koeun","family":"Shong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Setoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0247-7115","authenticated-orcid":false,"given":"Minho","family":"Shong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102939_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.xcrm.2026.102939_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102939_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrendo.2014.134","article-title":"Metabolism: WAT browning--key feature of cancer-associated cachexia","volume":"10","author":"Holmes","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.xcrm.2026.102939_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102939_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s42255-024-01011-0","article-title":"Activation of GPR81 by lactate drives tumour-induced cachexia","volume":"6","author":"Liu","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.xcrm.2026.102939_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102939_bib7","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.18632\/aging.205652","article-title":"Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients","volume":"16","author":"Yu","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.xcrm.2026.102939_bib8","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","article-title":"Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment","volume":"14","author":"Haake","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102939_bib9","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/2159-8290.CD-25-0293","article-title":"Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies","volume":"15","author":"Koh","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102939_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41591-023-02232-8","article-title":"Body composition and lung cancer-associated cachexia in TRACERx","volume":"29","author":"Al-Sawaf","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12885-018-4246-4","article-title":"GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer","volume":"18","author":"Zhao","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2026.102939_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.trecan.2025.06.007","article-title":"GDF15: from biomarker to target in cancer cachexia","volume":"11","author":"H\u00fcllwegen","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2026.102939_bib14","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.4103\/0366-6999.189052","article-title":"Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage I and II Nonsmall Cell Lung Cancer","volume":"129","author":"Liu","year":"2016","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.xcrm.2026.102939_bib15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2217\/fon.13.263","article-title":"Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer","volume":"10","author":"Blanco-Calvo","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.xcrm.2026.102939_bib16","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.jid.2016.07.016","article-title":"High GDF-15 Serum Levels Independently Correlate with Poorer Overall Survival of Patients with Tumor-Free Stage III and Unresectable Stage IV Melanoma","volume":"136","author":"Weide","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.xcrm.2026.102939_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.xcrm.2026.102939_bib18","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13539-012-0082-6","article-title":"Anorexia\/cachexia of chronic diseases: a role for the TGF-beta family cytokine MIC-1\/GDF15","volume":"3","author":"Tsai","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.xcrm.2026.102939_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021357118","article-title":"GFRAL-expressing neurons suppress food intake via aversive pathways","volume":"118","author":"Sabatini","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102939_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","volume":"7","author":"Lerner","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.xcrm.2026.102939_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","article-title":"The MIC-1\/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases","volume":"28","author":"Tsai","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102939_bib24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.tem.2020.10.004","article-title":"Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets","volume":"31","author":"Rochette","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2026.102939_bib26","first-page":"588","article-title":"Blocking GDF15 signalling reverses cachexia","volume":"19","author":"Crunkhorn","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102939_bib27","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111947","article-title":"GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia","volume":"42","author":"Kim-Muller","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102939_bib29","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the Treatment of Cancer Cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/1078-0432.CCR-23-1631","article-title":"A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia","volume":"30","author":"Crawford","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102939_bib31","first-page":"194","article-title":"Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy","volume":"24","author":"Neil","year":"2019","journal-title":"J. Pediatr. Pharmacol. Therapeut."},{"key":"10.1016\/j.xcrm.2026.102939_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.xcrm.2026.102939_bib33","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102939_bib35","doi-asserted-by":"crossref","first-page":"13456","DOI":"10.1093\/nar\/gku1115","article-title":"Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages","volume":"42","author":"Wan","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102939_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","article-title":"Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals","volume":"35","author":"Swayze","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102939_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152079","article-title":"Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model","volume":"131","author":"Li","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102939_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jcsm.12678","article-title":"Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function: lessons from human and animal studies","volume":"12","author":"Martin","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.xcrm.2026.102939_bib39","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.biocel.2013.05.016","article-title":"Muscle type and fiber type specificity in muscle wasting","volume":"45","author":"Ciciliot","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102939_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cmet.2019.12.004","article-title":"GDF15 Induces Anorexia through Nausea and Emesis","volume":"31","author":"Borner","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102939_bib41","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s41586-024-08305-z","article-title":"Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours","volume":"637","author":"Melero","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102939_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12974-022-02566-z","article-title":"Sensory neuron dysfunction in orthotopic mouse models of colon cancer","volume":"19","author":"Balogh","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102939_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1102282","article-title":"MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression","volume":"14","author":"Schr\u00f6rs","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102939_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102129","article-title":"GDF15 and LCN2 for early detection and prognosis of pancreatic cancer","volume":"50","author":"Zhu","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.xcrm.2026.102939_bib45","article-title":"PRMT1 promotes pancreatic cancer development and resistance to chemotherapy","volume":"5","author":"Ku","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib46","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s12276-025-01543-9","article-title":"GDF15 regulates development and growth of sympathetic neurons to enhance energy expenditure and thermogenesis","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2407326","article-title":"An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1","volume":"394","author":"Johnson","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102939_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/d41573-021-00213-5","article-title":"Antibody-oligonucleotide conjugates enter the clinic","volume":"21","author":"Mullard","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102939_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104858","article-title":"Antibody-oligonucleotide conjugates in cancer therapy: Potential and Promise","volume":"215","author":"Meng","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.xcrm.2026.102939_bib50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102939_bib51","article-title":"The tail suspension test","volume":"e3769","author":"Can","year":"2012","journal-title":"J. Vis. Exp."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:23:15Z","timestamp":1793060595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126003563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666379126003563"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102939","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Gfral silencing via antisense oligonucleotides ameliorates cancer-associated cachexia and extends survival in tumor-bearing mice","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102939"}}